Hengrui Medicine (01276.HK): As of the end of May, the company has repurchased a total of 12.0562 million A shares.

The Zhitong Finance and Economics APP reported that Hengrui Medicine (01276.HK) announced that in May 2026, the company repurchased 0 shares of stock through the Shanghai Stock Exchange trading system through centralized competitive bidding. As of May 31, 2026, the company has repurchased a total of 12.0562 million shares through the Shanghai Stock Exchange trading system as part of this stock repurchase plan, accounting for 0.18% of the company's total share capital. The highest purchase price was RMB 70.00 per share and the lowest price was RMB 53.52 per share. The total amount paid was RMB 771.9809 million (excluding transaction fees).